Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology
Market Cap
$1.26 Billion
CN¥9.22 Billion CNY
Market Cap Rank
#11864 Global
#2883 in China
Share Price
CN¥22.27
Change (1 day)
-1.29%
52-Week Range
CN¥19.35 - CN¥34.72
All Time High
CN¥71.90
About

Bio-Thera Solutions, Ltd., a biopharmaceutical company, researches and develops novel therapeutics for the treatment of cancer, autoimmune, cardiovascular, eye diseases, and other severe unmet medical needs in China and internationally. It offers QLETLI for the treatment of ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn's disease, and uveitis; POBEVCY to treat patients with metast… Read more

Bio-Thera Solutions Ltd - Asset Resilience Ratio

Latest as of December 2024: 4.09%

Bio-Thera Solutions Ltd (688177) has an Asset Resilience Ratio of 4.09% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥90.22 Million
Cash + Short-term Investments
Total Assets
CN¥2.21 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Bio-Thera Solutions Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Bio-Thera Solutions Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥90.22 Million 4.09%
Total Liquid Assets CN¥90.22 Million 4.09%

Asset Resilience Insights

  • Limited Liquidity: Bio-Thera Solutions Ltd maintains only 4.09% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Bio-Thera Solutions Ltd Industry Peers by Asset Resilience Ratio

Compare Bio-Thera Solutions Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Halozyme Therapeutics Inc
NASDAQ:HALO
Biotechnology 12.71%
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biotechnology 3.28%
ESSA Pharma Inc
NASDAQ:EPIX
Biotechnology 21.42%
Shenzhen CAU Technology Co Ltd
SHE:000004
Biotechnology 6.20%
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
Biotechnology 6.88%
Nanhua Bio Medicine Co Ltd
SHE:000504
Biotechnology 11.93%
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
Biotechnology 0.03%
Chengzhi Shareholding Co Ltd
SHE:000990
Biotechnology 6.73%

Annual Asset Resilience Ratio for Bio-Thera Solutions Ltd (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Bio-Thera Solutions Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 4.09% CN¥90.22 Million CN¥2.21 Billion -10.38pp
2023-12-31 14.47% CN¥331.03 Million CN¥2.29 Billion -14.42pp
2022-12-31 28.90% CN¥629.89 Million CN¥2.18 Billion +5.87pp
2021-12-31 23.03% CN¥602.83 Million CN¥2.62 Billion -16.91pp
2020-12-31 39.94% CN¥955.77 Million CN¥2.39 Billion --
pp = percentage points